As of 2015, he is continuing to work on initiating clinical trials for transplantation using lab grown dopaminergic neurons to treat Parkinson's disease [REF].
Current research efforts also include directing the fate and age of human pluripotent stem cells, and using pluripotent stem cells as valuable tools for modeling human diseases such as Familial Dysautonomia, Hirschsprung's disease, neurodevelopmental disorders, as well as melanocyte-related diseases.